In addition, PF4 is reportedly elevated in patients with antiphospholipid syndrome (APS) when platelet activity is increased, suggesting that PF4 could be a potential marker for DVT [3]. This evidence concerns the gene PF4 and autoimmune polyendocrinopathy.